Hepion Pharmaceuticals, Inc.
HEPA· OTC
HEPAHepion Pharmaceuticals, Inc.
Filed Feb 12, 2015 · 10-Q · 43 days after period end · 0001104659-15-009597
| Metric | Q2 2015 | Q2 2014 |
|---|---|---|
| Net Income | -$3.10M | -$168.16K |
| EPS Diluted | -$0.36 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Feb 12, 2015 · 43 d after period end
